This is to inform you that the Board of Directors of the Company at its meeting held on today, i.e., Thursday, February 12, 2026, has inter alia considered and approved the unaudited standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 3.6 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Salem Erode Investments Ltd, an NBFC, approved its unaudited standalone financial results for Q3 FY26 (quarter ended December 31, 2025) on February 12, 2026. Revenue from operations for the quarter stood at ₹81.89 lakhs, marginally up from ₹81.10 lakhs in Q3 FY25, but 9-month revenue declined to ₹279.39 lakhs from ₹296.51 lakhs in the same period last year. The company continued to post losses, with a net loss of ₹125.77 lakhs for the quarter (vs ₹136.33 lakhs loss in Q3 FY25) and ₹344.82 lakhs for the nine-month period. Total expenses remained elevated at ₹210.57 lakhs for the quarter, driven mainly by employee costs (₹97.80 lakhs) and finance costs (₹44.36 lakhs). The statutory auditor, Mohandas & Associates, issued an unmodified (clean) limited review conclusion.
The company is sustaining significant quarterly losses and its expenses far exceed its income, which is a concern for shareholders. While losses are slightly narrowing year-on-year, the lack of profitability and falling 9-month revenue suggest continued pressure on the stock. The clean audit review is a minor positive, but operational turnaround is not yet visible.